These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24919224)

  • 1. [Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013].
    Shen F; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):178-80. PubMed ID: 24919224
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 3. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
    Patel YA; Imperial JC; Muir AJ; Anstee QM; DeBrota D; Dimick-Santos L; Filozof C; Mehta R; Sanyal AJ; Schabel E; Neuschwander-Tetri BA; Miller V;
    Gastroenterology; 2017 Sep; 153(3):621-625.e7. PubMed ID: 28757264
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].
    Ströhle A; Stein J
    Med Monatsschr Pharm; 2015 May; 38(5):166-78; quiz 179-80. PubMed ID: 26364406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 9. NONALCOHOLIC FATTY LIVER DISEASE BRAZILIAN SOCIETY OF HEPATOLOGY CONSENSUS.
    Cotrim HP; Parise ER; Figueiredo-Mendes C; Galizzi-Filho J; Porta G; Oliveira CP
    Arq Gastroenterol; 2016; 53(2):118-22. PubMed ID: 27305420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community.
    Kasturiratne A; Akiyama K; Niriella MA; Takeuchi F; Isono M; Dassanayake AS; de Silva AP; Wickremasinghe RA; Kato N; de Silva HJ
    Liver Int; 2015 Feb; 35(2):676-9. PubMed ID: 24947803
    [No Abstract]   [Full Text] [Related]  

  • 11. A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.
    Nobili V; Donati B; Panera N; Vongsakulyanon A; Alisi A; Dallapiccola B; Valenti L
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):632-6. PubMed ID: 24345846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strengthen researches on risk factors and early diagnosis of nonalcoholic fatty liver].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):805-7. PubMed ID: 24516924
    [No Abstract]   [Full Text] [Related]  

  • 13. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 14. Foreword. Nonalcoholic Fatty Liver Disease.
    Day CP; Anstee QM
    Semin Liver Dis; 2015 Aug; 35(3):203-6. PubMed ID: 26378638
    [No Abstract]   [Full Text] [Related]  

  • 15. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease in 2020.
    Maher JJ; Schattenberg JM
    Gastroenterology; 2020 May; 158(7):1849-1850. PubMed ID: 32302525
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-alcoholic fatty liver diseases].
    Roeb E; Steffen HM; Bojunga J
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1846. PubMed ID: 26625237
    [No Abstract]   [Full Text] [Related]  

  • 18. Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?
    Lindenmeyer CC; McCullough AJ
    Cleve Clin J Med; 2017 Apr; 84(4):273-275. PubMed ID: 28388384
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management.
    Salomone F; Zelber-Sagi S; Galvano F; Fabbrini E
    Biomed Res Int; 2015; 2015():153276. PubMed ID: 26290862
    [No Abstract]   [Full Text] [Related]  

  • 20. Periostin on the road to nonalcoholic fatty liver disease.
    Polyzos SA; Anastasilakis AD
    Endocrine; 2016 Jan; 51(1):4-6. PubMed ID: 26585566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.